Price has hit the 1.414 (W 1.414) unless price goes past this level) I am not sure this last leg of the W has terminated, so the line is dashed instead of solid.
One more candle close down, I would feel it would be a solid line.
Things change and this stock is volatile!
No recommendation/NO PE Ratio assigned which would be highly unusual for a value stock.
Negative EPS.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Possibly an eventual short.
EPS (FWD)
-2.41
PE
-
Div Rate (TTM)
0
Short Interest
3.97%
Market Cap
$7.33B
One more candle close down, I would feel it would be a solid line.
Things change and this stock is volatile!
No recommendation/NO PE Ratio assigned which would be highly unusual for a value stock.
Negative EPS.
Inspire Medical Systems, Inc., a medical technology company, focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA) in the United States and internationally. The company offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe OSA. It also develops a novel, a closed-loop solution that continuously monitors a patient’s breathing and delivers mild hypoglossal nerve stimulation to maintain an open airway. The company was incorporated in 2007 and is headquartered in Golden Valley, Minnesota.
Possibly an eventual short.
EPS (FWD)
-2.41
PE
-
Div Rate (TTM)
0
Short Interest
3.97%
Market Cap
$7.33B